FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
- Atour relies on network expansion to counter economic slowdown
- After 14 years of losses, Zhihu finds an answer to its profitability question
- Overseas losses put wrinkle in H World’s welcome mat
- Yalla revenue growth returns to double-digits ahead of new gaming push
- Its knuckles rapped, recovering Gaotu springs back to the black
